[December 19, 2008] Appointments And Advancements Tweet (BioWorld Today Via Acquire Media NewsEdge) , of Cleveland, appointed Jake Orville president and CEO. Regado Biosciences Inc., of Basking Ridge, N.J., appointed Alexander R. Giaquinto senior vice president of regulatory affairs and quality assurance. Resverlogix Corp., of Calgary, Alberta, named Steven Nissen chairman of its Phase IIb IVUS steering committee. Committee members are Stephen Nicholls, Christie M. Ballantyne, John J. P. Kastelein and Allen Taylor. RXi Pharmaceuticals Corp., of Worcester, Mass., named Anastasia Khvorova chief scientific officer. Scottish Biomedical, of Glasgow, Scotland, named Alan Johnston nonexecutive director. Senesco Technologies Inc., of New Brunswick, N.J., appointed Harlan W. Waksal to its board. Sigma-Aldrich, of St. Louis, appointed Rakesh Sachdev vice president and chief financial officer. Sinobiomed Inc., of Shanghai, China, appointed Lionel Choong chief financial officer. Somnus Therapeutics Inc., of Bedminster, N.J., named Remy Luthringer, Gary Cutter, Charles A. Czeisler, Barbara A. Harris, Thomas Roth, James K. Walsh and Gary K. Zammit to its scientific advisory board. Sucampo Pharmaceuticals Inc., of Bethesda, Md., promoted Stanley G. Miele to senior vice president of sales and marketing. Summit Corp. plc, of Oxford, UK, appointed Tony Weir chief financial officer and board member. SuppreMol GmbH, of Martinsried, Germany, named Peter Sondermann chief scientific officer and named Uwe Jacob chief development officer. Thomas Hecht was appointed chairman, and Michael Motschmann will join the board. SuppreMol also named Fritz Melchers and Falk Nimmerjahn to its scientific advisory board. Sasha Tillmanns will join the company as medical director in January. Synageva BioPharma, of Waltham, Mass, appointed Mark Goldberg to its board. Synvista Therapeutics Inc., of Montvale, N.J., appointed William (Bill) Federici to its board. TheraGenetics Ltd., of Cambridge, Mass., appointed Peter Jones, Anil Malhotra and Pak Sham to its scientific advisory board chaired by Shitij Kapur. Tracon Pharmaceuticals Inc., of San Diego, appointed Bryan Leigh chief medical officer. Trillium Therapeutics Inc., of Toronto, named Michael Berendt and John Dietrich to its board. ? ? Copyright ? 2008 Thomson BioWorld, All Rights Reserved. [ Back To TMCnet.com's Homepage ]